格隆汇5月21日｜英国5月CBI工业订单差值 -41，预期-40，前值-38。

格隆汇5月21日｜宁波华翔公告，公司与布雷博股份公司及布雷博（南京）制动系统有限公司于2026年5月21日签署了《股东协议》，拟在中国设立两家合资公司，共同致力于智能底盘相关产品在中国的本地化产业落地与规模化应用。合资公司一注册资本为1亿元人民币，其中南京布雷博出资5,100万元，占比51%，公司出资4,900万元，占比49%；合资公司二注册资本为5,000万元人民币，其中公司出资2,550万元，占比51%，南京布雷博出资2,450万元，占比49%。

TLDRs; Amazon’s massive $33B Southeast Asia investment signals long-term expansion in cloud and AI infrastructure markets. The company expects major job creation and GDP gains across Indonesia, Malaysia, Singapore, and Thailand. AWS expansion strengthens Amazon’s global cloud leadership amid rising competition from Microsoft and Google. Satellite internet and AI training initiatives extend Amazon’s ecosystem beyond traditional cloud computing services. Amazon (AMZN) shares edged higher after the company announced a sweeping long-term investment plan exceeding $33 billion aimed at expanding its cloud computing and artificial intelligence infrastructure across Southeast Asia. The initiative, which spans Indonesia, Malaysia, Singapore, and Thailand, underscores Amazon’s aggressive push to deepen its global technology footprint. The market reaction reflected investor optimism that the investment will reinforce Amazon Web Services (AWS) dominance in one of the fastest-growing digital regions in the world. The company’s shares benefited from renewed confidence in its long-term revenue pipeline, especially as AI-driven demand for computing power continues to accelerate globally. $33B Regional Infrastructure Buildout Amazon confirmed on May 21 that the planned investment will be deployed through 2039, focusing heavily on expanding data center capacity, cloud infrastructure, and related operations across Southeast Asia. The company emphasized that this expansion is designed to support the region’s growing demand for digital services, enterprise computing, and artificial intelligence workloads. Amazon.com, Inc., AMZN According to Amazon’s projections, the initiative could have a significant macroeconomic impact. The company estimates it may support more than 56,300 full-time equivalent jobs annually across the four countries. In addition, it forecasts more than $64 billion in combined GDP contribution over the same timeframe, signaling a major economic footprint beyond its co...

格隆汇5月21日｜南下资金今日净卖出港股61.05亿港元。其中： 净买入经纬天地(新)12.41亿、中芯国际8.05亿、中国海洋石油4.25亿； 净卖出盈富基金24.75亿、阿里巴巴15.27亿、腾讯控股10.85亿、长飞光纤光缆2.62亿、华虹半导体2.57亿。 据统计，南下资金已连续5日净买入中芯国际，共计42.7071亿港元；连续4日净买入中海油，共计17.5497亿港元。 值得注意的是，经纬天地(新)今日股价闪崩暴跌超83%，跌至0.83港元，全天成交额放大至超46亿港元。

EschCollection/DigitalVision via Getty Images D-Wave Quantum Inc. ( QBTS ) is one of the many pure-play quantum companies in the market that is garnering attention from many investors. After a very bullish period in 2025, the stock has pulled back to much more reasonable levels. The company is hosting its first-ever investor day on June 1, and I believe this is exactly the catalyst the company needs. I have been bearish on the stock for a while , with my thesis largely hinging on valuation being way too stretched relative to the near-term opportunity. Of course, quantum has long-term staying power, and I believe many of the pure-play companies will be multiple times higher in 3-5 years from now. But short-term trading volatility - much like what was experienced during 2025 - can drive bearish opportunities. On the contrary, when quantum companies are progressing with their technology and produce early signs of broad commercialization, the upside reward can be significant. I believe D-Wave is approaching this intersection. Data by YCharts For those investors who got into the name early, there is not much motivation to sell at current levels. The recent pullback in shares has been felt across the quantum end-market, which I believe has been driven more by swings in investor sentiment than anything company-specific. 2025 brought forth significant amounts of investor optimism, which seems to have been met by a realization that quantum commercialization is still a few years away. Investors who are in the weeds with quantum know that this is nothing new. But sometimes, animal spirits take over a bullish run. D-Wave uses a process called quantum annealing , a computing technique that leverages quantum mechanics to find the lowest energy state of a system. This process essentially prepares the quantum system in all possible solutions, then adapts it towards the optimal configuration. While the company's approach is differentiated, there is no guarantee it will be successful...

格隆汇5月21日｜沪市ETF网上发行优化业务将于2026年5月25日正式启用，近期将组织通关测试，旨在支持指数化投资高质量发展、降低市场运行成本。根据2025年发布的方案内容，优化主要有三个方面：一是资金划付模式调整，认购期间不再向发行协调人滚动划付认购资金，改由中国结算上海分公司归集，募集结束后清算交收至ETF产品对应结算参与人资金账户；二是新增支持认购资金利息折算基金份额服务；三是优化了最小申赎单位的报送方式。

财联社5月21日讯（编辑 黄君芝） 美伊冲突爆发至今已经快三个月了，而油价始终在100美元高位附近徘徊。一位顶级策略师对接下来的情况预测称，美国经济有可能在7月份陷入衰退，标普500指数年内也有可能飙升至9000点，而这一切都取决于油价的走向。 美国知名投行Evercore ISI首席股票与量化策略师Julian Emanuel最新表示，美国经济很可能在初夏开始更强烈地感受到战争的影响。而 如果油价持续高企，他认为美国经济可能在7月4日陷入衰退。 他在接受最新采访时表示，如果原油价格保持在每桶93至98美元或以上，那么美国还有大约一个月的过渡时间，战争造成的损害就会最终波及到更广泛的经济领域。 Emanuel表示，随着夏季驾车出行高峰的到来，汽油价格在独立日（7月4日）当天成为人们热议的话题，美国人可能会开始更加意识到石油价格在独立日当天仍然维持在三位数的高位。 “到那时，战争的负面影响就开始显现了，”他补充道，并暗示美国人可能会开始削减其他领域的开支。 人们一直担心油价和天然气价格上涨最终会给美国消费者带来沉重负担，而这正是伊朗战争引发经济焦虑的核心所在。尽管4月份零售支出保持稳定，但消费者在加油站已经面临更大的压力。根据美国汽车协会（AAA）的数据，全美普通汽油的平均价格为每加仑4.55美元，远高于一年前的3.17美元。 与此同时，消费者价格指数和生产者价格指数在过去一个月里均升至多年来的最高水平。 Emanuel表示，他的团队也在关注油价上涨对股市的更广泛影响。 尽管Evercore ISI的基本预测是标普500指数年底将收于7750点，这意味着较当前水平有4%的上涨空间，但Emanuel指出，该指数短期内存在跌至6780点的风险，这意味着8%的下跌空间。 与此同时，阵亡将士纪念日（今年的5月25日）即将到来，这是另一个汽油价格备受关注的节日。即将到来的长周末将是对市场的又一次考验。他推测，如果美国人对即将到来的假期期间燃油价格的担忧加剧，可能会引发标普500指数的技术性回调，导致该指数下跌10%。 随着伊朗战争的持续，美国的经济和市场前景恶化。尽管强劲的盈利和科技、半导体行业的一系列并购活动支撑着股市，但对通胀的担忧正在逐渐加剧，投资者在上周抛售了部分行业的股票以及政府债券。 不过，Emanuel表示， 如果今年晚些时候乐观情绪回升，他预计该指数可能会飙升至...

Goldman Sachs campaigned to lead SpaceX's IPO, with Chief Executive Officer David Solomon messaging Elon Musk directly on X to highlight the bank's commitments. A rebound in US equities stalled while oil moved higher and bond yields wavered as traders once again waited to see whether hopes of a peace deal in the Middle East would translate into tangible progress. The Opening Trade has everything you need to know as markets open across Europe. With analysis you won't find anywhere else, we break down the biggest stories of the day and speak to top guests who have skin in the game. Hosted by Anna Edwards, Guy Johnson and Tom Mackenzie. (Source: Bloomberg)

记者了解到，全国股转公司最新下发通知，要求券商切实履行投资者适当性管理职责，严防新三板股票非法销售风险。通知要求，投资者适当性环节，券商面对法人及合伙企业开通权限需核查90日内验资报告或最近一期审计报告；重点核查“一人公司”、自然人出资人众多的合伙企业等群体，“一人公司”开户须临柜核实资金来源与真实意愿，投资者开通权限后60日内大额买入新三板股票需事后风险揭示。券商发现非法中介可疑迹象应及时报告，未勤勉尽责将被采取监管措施。（财联社）

深足、广州恒大、上海绿地申花、武汉三镇、山东鲁能泰山、北京国安、河南建业等知名足球俱乐部的原高管被处罚 【财新网】 再有足坛“假赌黑”行业处罚名单公布。5月21日，中国足球协会通报，对经法院认定构成犯罪的丁勇、吴静博等17人，给予终身禁止从事任何与足球有关的活动的处罚；对严重违反行业纪律的高寒、王波等48人，给予禁止从事任何与足球有关的活动五年或以下的处罚；对梅州客家足球俱乐部追加扣除2026年职业联赛积分6分并罚款80万元。 随通报一起公布的还有中国足协纪律与道德委员会作出的具体处罚决定。其内容显示，本次“终身禁业”的17人中有多家足球俱乐部的原高管。比如，原青岛中能足球俱乐部副总经理谭旭、原内蒙古中优足球俱乐部总经理史耀勇，原深圳市足球俱乐部总裁曾震宇和总裁助理丘杰华，以及原梅州客家足球俱乐部总经理曹阳、原青岛黄海足球俱乐部总经理孙迪等人，他们被指存在“为谋取不正当利益进行不正当交易”“操控足球比赛”等问题。

格隆汇5月21日｜中证协正对《证券公司从业人员业务培训细则》进行修订并征求意见中。《培训细则》主体内容未发生变化，但第十三条修改为“在一个培训周期内，证券公司应当要求其从业人员在党建引领、行业文化、廉洁要求、纪法知识、职业道德方面的学时比重不低于其应完成培训学时的35%。”此前监管通报过，部分券商对廉洁要求存在重视程度不到位、内控制度不严密、组织机制走形式、定期检查和考核问责走过场等问题，近年来，监管层面已持续将廉洁要求嵌入证券行业自律全链条，本次修订旨在通过培训前置要求，强化对职业操守底线的重视。

The third film in Tarik Saleh’s ‘Cairo trilogy’ is a about a washed-up movie star who is bullied into starring in government propaganda Swedish-Egyptian film-maker Tarik Saleh has long been a brilliant satirist of the corruption and shabby political compromises and conspiracies of post-Mubarak Egypt. Now he brings us the third of his “Cairo trilogy”, after The Nile Hilton Incident in 2017 and Cairo Conspiracy in 2022 . This new film is a seductive black-comic political thriller set in Egypt of the present day, showing us that everyone in the glamorous world of the movies, infatuated as they are with made-up stories acted out by narcissists believing in their own publicity, can so easily be pressed into the service of political propaganda. The result is a rackety, despairing, funny film with something of Billy Wilder, or István Szabó’s Mephisto, or Bertolucci’s fascism parable The Conformist. For me, it also had echoes of Daniel Kehlmann’s novel The Director, about 1930s Austrian movie director GW Pabst, fatally tempted by the blandishments of Goebbels. Saleh’s lead is his longtime leading man Fares Fares, playing an ageing Egyptian movie star; this is pampered matinee idol George Fahmy, a man comfortable doing cheesy crowd-pleasing potboilers, now bullied into playing the lead in a sinister government-sponsored biopic of the president (with news footage of the current president, Abdel Fatah al-Sisi, cheekily cut in). Continue reading...

A previously undetected outbreak of Ebola is coursing through parts of central Africa, and the US appears to be doing little to help stop it, after massive cuts to global and domestic public health efforts. There is no cure and no vaccine for the rare Bundibugyo variant of Ebola, which has caused two outbreaks in recent decades. Health leaders and scientists are now racing to understand where the virus is spreading and attempting to stop it – but the US is notably absent in these efforts. In the past year, the US Agency for International Development (USAID) has been dismantled, thousands of staff at US health agencies were laid off, communications stalled and key scientific research canceled. There are 482 suspected cases and about 116 deaths reported since April in the Democratic Republic of the Congo (DRC), with two cases and one death in Uganda and potential spread to neighboring South Sudan. The outbreak “might have been going on for a few months”, said Kristian Andersen, a professor of immunology and microbiology at Scripps Research. The outbreak was immediately declared a public health emergency of international concern (PHEIC) by Tedros Adhanom Ghebreyesus, the director general of the World Health Organization (WHO), before even convening the committee that usually makes that determination. Officials say it may last for months. “The DRC is one of the most vulnerable health systems in the world, and was the second-biggest recipient of USAID funding,” said Matthew Kavanagh, director of the Center for Global Health Policy and Politics at Georgetown University. The US withdrawal of funding with “zero notice” has been “disruptive to the country’s basic activities”, he said. US foreign assistance to the DRC dropped from $1.4bn in 2024 to $431m in 2025 and only $21m so far this year. Assistance to Uganda dropped from $674m to $377m in 2025 and a negative $1.2m so far in 2026. “It was pennies compared to what you get in return,” Andersen said of global health investm...

A top influencer in China has announced a halt to updates of his social media account for the sake of his health, arousing significant nationwide attention. The announcement comes after the sudden deaths of a slew of online celebrities at a young age due to work pressure, the Liaoshen Evening News reported. Wang Bowen, who uses the handle @dalianlaoshiwangbowen on social media and has amassed more than 20 million followers, said in mid-May that he would stop releasing videos for an “indefinite duration”. Advertisement “Intense content creation for the past 13 years has overdrafted my physical and mental health. I have got health problems like tinnitus, depression, anxiety and heart disease,” Wang said in his latest video. Wang Bowen, above, produces zany content based in an urban setting. Photo: Baidu The blogger, who was born in the 1990s and lives in Dalian, Liaoning province, northeastern China, said he would feel sick and anxious whenever he saw a camera or face questions about when he would release new videos.

While Canada may be clinging to fossil fuels, much of the world is moving on Casual international observers would be forgiven for assuming Canada is in the comforting hands of a climate champ. After all, while climate policy rollbacks reign supreme in Donald Trump’s America, Canada is now led by a man who, while serving as governor of the Bank of England, delivered a celebrated 2015 speech, “ Breaking the tragedy of the horizon ”, warning the global investment community of the financial risks of climate change; who went on to serve as UN special envoy for climate action and finance ; and whose 2022 book Value(s) had much to say about the “existential threat” of climate change. A man who recently dazzled the world with his Davos speech on how middle powers can stand up to global bullies. Look, we get it. Next to the US president, Carney seems so debonair, thoughtful and calm – a lifeline of stability in a volatile new world. Seth Klein is a Canadian climate writer and activist, author of the book A Good War: Mobilizing Canada for the Climate Emergency , and former team lead of the Climate Emergency Unit . His newsletter can be found here . Continue reading...

Maths was never my thing. I quite enjoyed it at O-level, to the extent that I chose to do it at A-level. As early as the first week of the A-level course, however, it became abundantly clear that the subject was quite beyond me. I simply couldn’t make head or tail of what the teacher was on about. Looking around at the rest of the class quietly getting on with it, I remember wondering if there had been some primer course over the summer that everyone but me had attended. I just didn’t get it. There didn’t seem to be any certainties any more, rarely anything so straightforward as a right or wrong answer. There were enough grey areas in my other subjects – English and history. From my maths I wanted certainty, objective truth, which as far as I could see wasn’t part of it any more. Where were the times tables, for example? I’d nailed those good and proper at a very early age. In ascending order of difficulty I would rate them as follows: two, 10, five, 11, three, four, six, eight, seven and 12. You’ll notice that the nine times table does not feature on this list. Why? Well, I found it too easy. It was my speciality. But that’s because I was cheating – or so it felt – as someone had showed me a quick trick with which to nail the nines, as it were. For this reason, I was fascinated to read that in an analysis of times tables answers by primary school children, it was ones that involved the number nine that were most often wrong. They’re not the only ones. When the then school standards minister Nick Gibb announced the rollout of national multiplication tests in 2018, he refused to attempt 8x9 on ITV’s Good Morning Britain. What’s the matter with everyone? Nines are easy! If you kind of cheat, like me. What you do is this. Hold your hands up, palms facing you. If it’s 8x9 you’re interested in, just fold down the eighth digit from the left, which will be the middle finger of your right hand. Now count the number of digits still standing to the left of the one you’ve fold...

okies3D/iStock via Getty Images Market review and outlook The Bloomberg 1-3 Year Government/Credit Index returned 0.28% in Q1, its lowest quarterly return since Q4 2024 (-0.02%). Through the first two months of the year, the index returned 0.75% as economic data remained broadly resilient despite concerns around the February sell-off in software stocks, a key tariff decision by the Supreme Court and the growing drumbeat of war in the Middle East. The US and Israel launched combat operations against Iran on February 28, and the markets spent most of March reeling from the ongoing conflict, resulting in Brent crude oil experiencing its biggest quarterly increase since the Gulf War in 1990. While one normally thinks of a flight-to-quality trade as a rally in Treasury yields as investors move away from risk assets to safer alternatives, this was not the case in March as rates pushed higher across the curve. The Fed held rates steady at the March 18 meeting and avoided any kind of hints about the future path of rates. Despite concerns around the impact of higher energy prices on inflation due to the conflict, no participants viewed a 2026 hike as appropriate at this time. At his press conference, Chairman Jerome Powell alleviated some concern around the leadership of the Federal Reserve, stating that he would remain as chair pro tempore until his replacement is confirmed. Updates by sector Treasury The entire Treasury yield curve pushed higher in Q1, with most of the shift taking place in March after combat operations began in the Middle East. The 2-year Treasury yield climbed 41.8 basis points (BPs) in March, marking its biggest monthly move since October 2024 when ongoing strength in economic news had investors reconsidering rate cut expectations. The dramatic shift in March was more than enough to offset some of the compression in yield during the first two months of the year, resulting in an increase of 32 bps during Q1. But the trend higher impacted the entire curve...

Elon Musk ’s SpaceX pulled back the curtain on a business empire that has racked up ballooning losses and debt after acquiring a cash-hungry startup, and pumping billions of dollars into futuristic endeavors ranging from AI to a Mars rocket. The prospectus that SpaceX filed Wednesday for an IPO of unprecedented size boiled down to a well-worn strategy that entrepreneurs commonly hawk up and down Wall Street: in order to make money, we need to spend money. And nowhere are the outlays larger than in space and artificial intelligence. “The big takeaway for me is that SpaceX is now an AI company,” said Chad Anderson , an early SpaceX investor and founder of Space Capital. Musk is seeking to pull off the unprecedented feat of achieving a $2 trillion valuation from the outset, an audacious plan that’s set to transform both the public and private markets if it succeeds. At the same time, the prospectus lays bare concerns over whether private companies with limited financial disclosures and largely illiquid shares are reaching unjustified valuations in venture capital-led funding rounds. “Investors aren’t paying for today’s business, they’re paying for the platform that owns the next 50 years of orbital infrastructure,” Anderson said. The company’s future projections, even when championed by a celebrity figure like Musk, are nothing short of extreme. SpaceX states that their total addressable market, or maximum revenue ceiling, is $28.5 trillion, by far the largest in history, according to the filing. Nearly all of that would come from AI, with space making up $370 billion and Starlink-based connectivity $1.6 trillion. Mike Alves, founder and fund manager of VIDA Vision Fund and early investor in SpaceX, said it’s a “shocker” how aggressively the company is pitching its AI capabilities. “For a rocket company, that’s wild,” Alves said. Then again, buried in a filing of over hundreds of pages were glimmers of financial promise. The company reported $18.7 billion in 2025 reven...

Amid allegations of abuse on Epstein's 'Zorro Ranch,' New Mexico opens new probes toggle caption Roberto E. Rosales/Getty Images North America On International Women's Day in March, hundreds of protesters caravanned out to a spot in the desert outside of Santa Fe. Their gathering place was a ranch in the high desert of New Mexico that once belonged to the late financier and sex offender Jeffrey Epstein. One of the demonstrators at the rally at the ranch was Virginia Giuffre's brother, Sky Roberts. Giuffre, who died by suicide in 2025, was one of Epstein's most prominent accusers and said she had been sexually abused at the ranch . Roberts referred to two investigations recently started by New Mexico officials. toggle caption Daniel Montaño/KUNM "This is what we need to see more of state by state. I think New Mexico is taking the first initiative. I think the people of New Mexico are demanding answers, they're demanding justice," Roberts said. "It starts here and there's so much more that we can continue to fight for." Sponsor Message In addition to his more well-known properties, including his Manhattan mansion and his private Caribbean island, Epstein owned this property, known as the Zorro Ranch. It housed a mansion, an airstrip and 10,000 acres of scrubland. For decades there have been suspicions – some noted by officials – and even talk-radio chatter, of crimes at the ranch, including claims bodies are buried on the grounds. Connections have been drawn to several prominent figures, and court documents place some of the earliest accusations of abuse at the ranch . Now New Mexico officials say they're seeking the truth of what happened there with the two investigations. The state's attorney general's office announced in February it was re-opening an old investigation that was closed in 2019 at the request of federal prosecutors in New York. New Mexico's justice department went on to perform a search of the vast property with search and rescue dogs. toggle caption ...

is a senior editor and founding member of The Verge who covers gadgets, games, and toys. He spent 15 years editing the likes of CNET, Gizmodo, and Engadget. Posts from this author will be added to your daily email digest and your homepage feed. Bambu Lab makes the best, most accessible 3D printers yet, but that reputation is suddenly under siege. It all started when Paweł Jarczak received a private message from the company on Reddit asking him to delete his code. Now the 3D printing community is lining up behind Jarczak to fund a war against Bambu — and the future of 3D printers could be at stake. Jarczak is a developer who shared a way to let people remote control their Bambu printers without using Bambu software. But Bambu wanted to lock down its system, despite relying on open-source code. That provoked a furious coalition of open-source advocates and YouTubers to respond. “I’ll put up $10,000 to teach bambu labs a lesson,” declared consumer rights advocate Louis Rossmann, pledging to help defend Jarczak in court. “I’m never buying a Bambu Lab 3D printer again,” stated maker Jeff Geerling, adding that he’d gladly chip in too. (He’s changed the YouTube title since.) “Go fuck yourself, Bambu,” wrote GamersNexus, pledging to commit $10,000 as well. (It’s also halting previously unannounced plans to buy $150,000 of Bambu hardware for a 3D printing project, editor-in-chief Steve Burke tells The Verge.) “Go ahead, Bambu: Sue us,” taunts GamersNexus, which has also begun investigating scattered reports of a Bambu printer catching fire. If that wasn’t enough, Rossmann, Burke, and thousands of other open-source advocates are daring Bambu to take legal action — they’re each forking the code Bambu was hoping to suppress. As of Monday, so is the Software Freedom Conservancy, which is now hosting an entire project to reverse engineer Bambu’s code and says it will serve as a Bambu watchdog. “They’re bad actors, straight-up, and the community should do whatever we can,” Bradley...

Researchers say the Trump administration is finding new ways to punish science toggle caption Jodi Hilton for NPR Standing in his laboratory, Harvard professor Sean Eddy gazes at a row of vacant work stations. More than a year ago, this lab was filled with over a dozen researchers. On a given day they might be working independently on analyzing genomic sequencing or gathered around the group table, drinking coffee and helping each other troubleshoot questions about genomic data from different species. Now, after his funding was terminated under the Trump administration, the computer screens are gone and the room is silent. He's one of the last people left. " Seeing these labs empty — this is not the way it's supposed to be," he says. "This was a very vibrant lab." Sponsor Message Eddy is a computational biologist. He has devoted his career to one fundamental question. " I'm really interested in the origin of life," he says. "I want to know where it all came from." He and his colleagues spent years developing software that could be used to seek out an answer. Scientists around the world now use the tools his team created to compare DNA and protein sequences, identify genes, and predict what they do. Their work underpins countless studies, including research related to cancer and neurodevelopmental disorders. It's hard to quantify how much modern science relies on what his team built. Eddy describes its use as being as ubiquitous as microscopes or pipettes. "It's very affirming for me to pick up sort of semi-random papers in the literature in fields that I care about and see them using our software over and over again," he says. When the lab was designed more than a decade ago, he worked closely with an architect. On the wall are pictures of animals. His daughter, who was 12 at the time, stenciled them for him. Mixed in with pictures of mice and fish are laboratory creatures. "There's a bacterial virus called T4 that I did my thesis on," he says, pointing to the wall....

Quarterly Total Revenues Reached RMB25,532.7 Million (US$3,701.5 Million)i Quarterly Vehicle Deliveries Were 83,465 Units SHANGHAI, China, May 21, 2026 (GLOBE NEWSWIRE) -- NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced its unaudited financial results for the first quarter ended March 31, 2026. Operating Highlights for the First Quarter of 2026 Vehicle deliveries were 83,465 in the first quarter of 2026, representing an increase of 98.3% from the first quarter of 2025, and a decrease of 33.1% from the fourth quarter of 2025. The deliveries consisted of 58,543 vehicles from NIO brand, 13,339 vehicles from ONVO brand, and 11,583 vehicles from FIREFLY brand. Key Operating Results 2026 Q1 2025 Q4 2025 Q3 2025 Q2 Deliveries 83,465 124,807 87,071 72,056 2025 Q1 2024 Q4 2024 Q3 2024 Q2 Deliveries 42,094 72,689 61,855 57,373 Financial Highlights for the First Quarter of 2026 Vehicle sales were RMB22,783.7 million (US$3,302.9 million) in the first quarter of 2026, representing an increase of 129.2% from the first quarter of 2025 and a decrease of 27.9% from the fourth quarter of 2025. were RMB22,783.7 million (US$3,302.9 million) in the first quarter of 2026, representing an increase of 129.2% from the first quarter of 2025 and a decrease of 27.9% from the fourth quarter of 2025. Vehicle margin ii was 18.8% in the first quarter of 2026, compared with 10.2% in the first quarter of 2025 and 18.1% in the fourth quarter of 2025. was 18.8% in the first quarter of 2026, compared with 10.2% in the first quarter of 2025 and 18.1% in the fourth quarter of 2025. Total revenues were RMB25,532.7 million (US$3,701.5 million) in the first quarter of 2026, representing an increase of 112.2% from the first quarter of 2025 and a decrease of 26.3% from the fourth quarter of 2025. were RMB25,532.7 million (US$3,701.5 million) in the first quarter of 2026, representing an increase o...

"The FRUSICA-2 trial results provided compelling evidence that the sintilimab and fruquintinib combination could play a meaningful role in shaping second-line treatment strategies for advanced renal cell carcinoma," said Professor Zhisong He of Peking University First Hospital and co-lead Principal Investigator of the FRUSICA-2 study. "We are optimistic about the clinical implications of this approval as we strive to provide effective treatment options for patients." "The rapid advancements in targeted therapies, immunotherapies, and their combination regimens have led to a significant evolution in the treatment landscape for advanced renal cell carcinoma. Optimizing the selection of treatment for individual patients is a key focus of clinical interest," said Professor Dingwei Ye of Fudan University Shanghai Cancer Center and co-lead Principal Investigator of the FRUSICA-2 study. "The approval of the sintilimab and fruquintinib combination underscores its potential to address the pressing medical needs of patients with this challenging disease." The approval is supported by data from FRUSICA-2, a randomized, open-label, active-controlled registration study evaluating the efficacy and safety of sintilimab in combination with fruquintinib versus axitinib or everolimus monotherapy for the second-line treatment of patients with locally advanced or metastatic renal cell carcinoma. The study met its primary endpoint of progression free survival (PFS) as assessed by blinded independent central review (BICR). SAN FRANCISCO and SUZHOU, China, May 21, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and HUTCHMED (China) Limited (" HUTCHMED ") (Nasdaq/AIM:HCM; HKEX:13), today jointly announce that the New Drug Application (NDA) for the combination of TYVYT ® (sintilima...

“This approval reaffirms our deep commitment to delivering innovative therapies to patients facing advanced renal cell carcinoma in China, where second-line treatment options remain limited,” said Mr Johnny Cheng, Acting Chief Executive Officer and Chief Financial Officer of HUTCHMED . “We are excited to continue pushing the boundaries of our research — across monotherapies, combination strategies, and exciting new platforms such as our ATTC technology — to unlock even greater therapeutic potential across various tumor types, ultimately providing more impactful and transformative solutions to patients.” “The FRUSICA-2 trial results provided compelling evidence that the fruquintinib and sintilimab combination could play a meaningful role in shaping second-line treatment strategies for advanced renal cell carcinoma,” said Professor Zhisong He of Peking University First Hospital and co-lead Principal Investigator of the FRUSICA-2 study. “We are optimistic about the clinical implications of this approval as we strive to provide effective treatment options for patients.” “The rapid advancements in targeted therapies, immunotherapies, and their combination regimens have led to a significant evolution in the treatment landscape for advanced renal cell carcinoma. Optimizing the selection of treatment for individual patients is a key focus of clinical interest,” said Professor Dingwei Ye of Fudan University Shanghai Cancer Center and co-lead Principal Investigator of the FRUSICA-2 study. “The approval of the fruquintinib and sintilimab combination underscores its potential to address the pressing medical needs of patients with this challenging disease.” The approval is supported by data from FRUSICA-2, a randomized, open-label, active-controlled registration study evaluating the efficacy and safety of fruquintinib in combination with sintilimab versus axitinib or everolimus monotherapy for the second-line treatment of patients with locally advanced or metastatic renal cell c...

Data from the all-oral combination of BeOne’s foundational BCL2 inhibitor sonrotoclax plus zanubrutinib (ZS) in CLL , which demonstrated deep responses, unprecedented speed to undetectable MRD, and durable remissions and a generally well-tolerated safety profile. These data reinforce the potential for a next-generation, time-limited approach designed to deliver long-term outcomes without compromising durability or safety. Data will be presented as a poster at ASCO 2026 and an oral presentation at EHA 2026. Oral presentation at EHA 2026 of updated data of BeOne’s foundational BTK degrader – BGB-16673 – in patients with R/R CLL , demonstrating promising and durable activity and a manageable safety profile. An additional poster will be shared featuring never-before-presented data of BGB-16673 in BTK-naïve patients. BGB-16673 is the most advanced BTK degrader in the clinic, with more than 1,100 patients dosed. A subgroup analysis of SEQUOIA, which includes one of the largest and longest-followed cohorts of patients aged ≥80 years ever reported in a Phase 3 CLL study , showing that age did not limit benefit. Data will be presented at EHA 2026. New results from the SEQUOIA trial with 78 months follow-up reinforce BRUKINSA ® (zanubrutinib) as the foundational BTK inhibitor in CLL, with durable disease control that continues to raise expectations for what patients and physicians should expect from first-line therapy over the long term. Data will be presented at both ASCO and EHA. "Seventy-eight-month follow-up data from SEQUOIA underscore what it truly takes to lead in CLL over the long term: long-term efficacy, ability for sequencing treatments, and confidence in first-line treatment decisions. Building on that leadership, we’re excited to be rapidly advancing the next generation of medicines, including sonrotoclax-based combinations and our BTK degrader BGB-16673, which are designed to extend what is possible for patients across lines of therapy." At ASCO and EHA 2026, Be...

0:00 spk_0 All right. Welcome to a new episode of Power Players. I'm your host, Brian Sazi, and we are taping this episode at the Milken Institute conference in Los Angeles, and I'm, it's a real honor to welcome on my next guest to this episode, uh, artist, composer, producer, entrepreneur, Wyclef. It's so good to see you. Like, it's a real honor to have you here, seriously, I appreciate it. Um you, man. What bringsyou to Milken? 0:22 spk_1 Um, well, first of all, thank you to Milke for having me. And I would say in the past, uh, 30 years, um, I started off at the Fugees, and I think a lot of times people look at the music and behind the music is the engineering. So, as an engineer, I started with hardware, uh, software conversion, uh, streaming.To AI Music, uh, I've been progressive in the process, I've been part of a few companies, one of them being Open Wave. I'm, uh, I also, I'm also a consultant for Google DeepMind.Um, division, um, so just I'm here as we move towards the future. The, the future of music is being shaped differently to talk about like how I see us moving forward in the next 10 years. 1:08 spk_0 The lasttime I saw you, it was maybe 2 or 3 years at Davos at a Google event. Um, that's why I was so excited to see you on the list for this one. You came and you played, I think you played a guitar, but then you talked about how AI was changing.The music industry and now fast forward 2+ years we're here. Like what changes are you seeing? 1:28 spk_1 Well, the changes, one of the main changes we're seeing is accessibility on how easier it is to do music with the two. the other, uh, trend that we're seeing is, uh, the, the music AI, uh, gets refused a lot by super creators.But the average norm person like my wife is the most amazing thing to her. So, um, so, and, and now it's, it's normality, right? Um, to do music, you have to have these studios, you have to have a sense of, um, you know, how these notes are going, how these beats are going now, whatever ...

The 2027 Social Security cost-of-living adjustment (COLA) wasn't supposed to be anything special, according to the earliest forecasts. The Senior Citizens League (TSCL), a nonpartisan senior group, initially predicted that the COLA would fall somewhere between 2.5% and 2.8%. But rising inflation has begun to change that picture. Some are now wondering if the 2027 COLA will exceed 4%. While we can't know for sure until the official announcement in October, recent projections give us a rough idea of where Social Security benefits could be headed next year. The 2027 COLA is likely to be higher than previously expected TSCL's 2027 Social Security COLA prediction rose from 2.8% in April 2026 to 3.9% in May 2026. A 1.1 percentage point increase in a single month is unusual, and it reflects concerns about rising inflation. The Consumer Price Index used to calculate Social Security COLAs revealed that inflation rose by 3.8% in April 2026, up from 3.3% the month before. This has largely been driven by higher gas prices, though other costs have increased as well. If inflation continues to rise, a 2027 COLA of 4% or more is a real possibility. A 4% increase would add $83 to the $2,081 average retirement benefit as of April 2026. That would give the typical senior nearly $1,000 more throughout the year, and some people may see a much larger increase if they're currently receiving an above-average benefit. The reality of a 4% Social Security COLA While a 4% Social Security COLA might sound like an improvement over the 2.8% boost seniors saw this year, it's important to remember that larger COLAs appear alongside rising living costs. Regardless of the size of the 2027 COLA, it's unlikely to drastically change your quality of life. You'll still need personal savings and possibly a job to cover what your Social Security benefits won't. If you're struggling to make ends meet, you may need to look into other government benefits as well to help you with your essential costs, like food...